Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 22, 1996

View Archived Issues

Antithrombotic/antiallergic agents from Terumo

Antidiabetic agents reported by Terumo

New carbapenems from Takeda

Otsuka describes novel cephems

Japanese researchers disclose anti-HIV agents

Antitumor lactam isolated by Japanese researchers

Mercian discloses novel mitomycin

Antiparkinsonian skin patch enters pivotal phase II trial

RA test from Hemagen Diagnostics cleared for marketing

LecTec cleared to proceed with clinical testing of smoking cessation product

New impotence treatment deemed approvable by FDA

Alkermes and Genentech expand collaboration for sustained-release human GH

MDV acquired by Alliance

Novavax reports progress on products for H. pylori infection

Theratechnologies and AEterna sign technology licensing agreement

Company Profile: Lexicon Genetics

Lamotrigine now available in France

Another French market introduction for Lescol

New market introduction for ReoPro

Company profile: Molecumetics

Candela laser systems approved in Japan

New target for drug-resistant tumors identified

Quidel and Bayer collaborate on diagnostic tests

LeukoSite and Warner-Lambert collaborate on drugs blocking the CCR5 receptor

Calcium channel blocker update

ACE inhibitor-AT antagonist combination therapy results presented at AHA congress

Interim clinical results with Ansan's cancer product

RESTORE trial results presented at AHA meeting

Guilford's orally active neuroimmunophilin highly effective in animal models of Parkinson's disease

NeoTherapeutics' lead small molecule advances toward clinical trials in AD

NCI sponsors clinical trials with Therion's prostate cancer vaccine

PDL anti-HBV antibody enters phase II

OraVax, bioMerieux licensing agreement for H. pylori diagnostic technology

FDA issues approvable letter for Nycomed diagnostic

Favorable phase I results reported for NC-100100

Cytel/Abbott collaboration reaches milestone

Chiroscience to acquire U.S. gene-based biotech company

Cortecs plans oral insulin studies in diabetic patients

IDEC to present final pivotal data on IDEC-C2B8

SKB to begin pivotal trials with antibody for RA

Genentech advances NGF through the clinical development pipeline

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...